Skip to content
DraconiticResearch
Search Sources API
182,460 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BY-NC-NDBMC medical genomics

Identification of glutathione metabolism-related biomarkers in non-alcoholic fatty liver disease based on single-cell and bulk RNA sequencing.

  1. 1Clinical Medical College of Qinghai University, Qinghai, China.
  2. 2Department of Hepatology II, Fourth People's Hospital of Qinghai Province, Qinghai, China.
  3. 3Department of Public Health and Hospital Infection Management, Qinghai University Affiliated Hospital, Qinghai, China. [email protected].

Abstract

Background

Glutathione (GSH) metabolism plays a crucial role in the development and progression of non-alcoholic fatty liver disease (NAFLD), yet its molecular mechanism remains unclear.Methods

Bulk transcriptome and single-cell data from the Gene Expression Omnibus (GEO) database were analyzed using single-cell RNA sequencing (scRNA-seq) and five algorithms for Glutathione metabolism-related genes (GMRGs) scores to identify key cell types and biomarkers. Core candidate biomarker was validated by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting in palmitic acid (PA)-induced HepG2 cells.Results

Cholangiocytes showed the highest GMRG-related transcriptional activity among the annotated cell populations. Through screening, 4 potential biomarkers (CSTA, DDAH2, OAZ2, TYMP) were found, with DDAH2 as the core due to its high expression and strong correlation with GMRGs. Enrichment analysis suggested that DDAH2 expression was associated with energy metabolism and protein homeostasis pathways. DDAH2-high cholangiocytes showed stronger computationally inferred interactions with B cells and endothelial cells, mainly involving the "MIF-(CD74 + CXCR4)" and "APP-CD74" pathways, and were enriched in early pseudotime states. In vitro, DDAH2 expression was significantly up-regulated in NAFLD, providing preliminary support for the expression trend.Conclusion

This study identified cholangiocytes as the annotated cell population with the strongest GSH metabolism-related transcriptional signature in the analyzed NAFLD scRNA-seq dataset and highlighted four related biomarkers, with DDAH2 prioritized as the core candidate biomarker.

Related

  1. Identification and validation of candidate biomarkers associated with mitochondrial metabolism in diabetic foot
    Haifeng Li, Yijie Ning, Chuanlong Lu +9
    BMC Endocrine DisordersPeer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismPMC
  2. Integrated Analysis of Serotonin-Related Biomarkers in Thoracic Aortic Aneurysm Based on Machine Learning and Single-Cell Sequencing Data
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Integrating single-cell RNA sequencing and transcriptome analysis to explore uric acid–related biomarkers and regulatory mechanisms in preeclampsia
    Yingping Liu, Lei Hou, Chengmao Xie +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsCrossref
  4. Synthetic Cannabinoids: Metabolism, Biomarkers of Exposure and Advanced Analytical Strategies in Forensic and Clinical Toxicology
    Telma M. Gomes, Paula Guedes de Pinho, Ivone Nunes +1
    ToxicsPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  5. Tryptophan Metabolism in Pediatric Atopic Dermatitis: Shared Mechanisms, Age-Specific Biomarkers, and Emerging Therapies
    Marta Dyszkiewicz, Beata Cudowska, Wioleta Justyna Omeljaniuk +2
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{zhao2026identification,
  title = {{Identification of glutathione metabolism-related biomarkers in non-alcoholic fatty liver disease based on single-cell and bulk RNA sequencing.}},
  author = {Yinan Zhao and Guoying Yu and Lu Zhao},
  journal = {BMC medical genomics},
  year = {2026},
  month = jul,
  doi = {10.1186/s12920-026-02444-0},
  url = {https://europepmc.org/article/MED/42958345},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Identification of glutathione metabolism-related biomarkers in non-alcoholic fatty liver disease based on single-cell and bulk RNA sequencing.
AU  - Yinan Zhao
AU  - Guoying Yu
AU  - Lu Zhao
PY  - 2026
DA  - 2026/07/29
JO  - BMC medical genomics
DO  - 10.1186/s12920-026-02444-0
UR  - https://europepmc.org/article/MED/42958345
AB  - Background  Glutathione (GSH) metabolism plays a crucial role in the development and progression of non-alcoholic fatty liver disease (NAFLD), yet its molecular mechanism remains unclear.Methods  Bulk transcriptome and single-cell data from the Gene Expression Omnibus (GEO) database were analyzed using single-cell RNA sequencing (scRNA-seq) and five algorithms for Glutathione metabolism-related genes (GMRGs) scores to identify key cell types and biomarkers. Core candidate biomarker was validated by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting in palmitic acid (PA)-induced HepG2 cells.Results  Cholangiocytes showed the highest GMRG-related transcriptional activity among the annotated cell populations. Through screening, 4 potential biomarkers (CSTA, DDAH2, OAZ2, TYMP) were found, with DDAH2 as the core due to its high expression and strong correlation with GMRGs. Enrichment analysis suggested that DDAH2 expression was associated with energy metabolism and protein homeostasis pathways. DDAH2-high cholangiocytes showed stronger computationally inferred interactions with B cells and endothelial cells, mainly involving the "MIF-(CD74 + CXCR4)" and "APP-CD74" pathways, and were enriched in early pseudotime states. In vitro, DDAH2 expression was significantly up-regulated in NAFLD, providing preliminary support for the expression trend.Conclusion  This study identified cholangiocytes as the annotated cell population with the strongest GSH metabolism-related transcriptional signature in the analyzed NAFLD scRNA-seq dataset and highlighted four related biomarkers, with DDAH2 prioritized as the core candidate biomarker.
SN  - 1755-8794
ER  -